Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
fda
3
×
life sciences
national blog main
amgen
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
episodic migraine
indiana blog main
indiana top stories
national top stories
san francisco blog main
san francisco top stories
teva pharmaceutical
alder biopharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cstone pharmaceuticals
david rind
deals
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
european medicines agency
fisogatinib
flatiron health
food and drug administration
fremanezumab
galcanezumab
genentech
hepatocellular carcinoma
What
approval
3
×
drug
fda
medicines
3
×
class
developed
migraine
new
pain
starts
won
amgen
announced
approved
blueprint
cancer
candidate
candidates
currently
decision
eli
gets
head
headache
late
lilly
marketing
marks
muscle
nod
pact
prevent
preventive
regulatory
ret
review
roche
team
thursday
wins
Language
unset
Current search:
medicines
×
fda
×
approval
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines